SINTX Technologies Provides Mid-Year 2026 Business Update Highlighting Commercial Execution, Biomaterial Platform Expansion and Strategic Growth Initiatives

Stock Information for SiNtx Technologies Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About SiNtx Technologies Inc.

SINTX Technologies Announces Silicon Nitride Masterclass with Leading Orthopedics Experts
SINTX Technologies to Present at the H.C. Wainwright 28th Annual Global Investment Conference
SINTX Technologies Regains Compliance with Nasdaq Stockholders' Equity Requirement
SINTX Technologies Announces Second Quarter 2026 Earnings Release Date and Webcast
SINTX Technologies Engages Veteran MedTech Executive Chris Lyons and Southern Metrics to Establish Strategic Opportunity Management Program
SINTX Technologies Announces Receipt of More Than $3.2 Million in Contract Manufacturing Purchase Orders
SINTX Technologies Announces Raise of Approximately $5.0 Million of Capital, Including a $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules
SINTX Technologies Provides Corporate Business Update Highlighting First Human Implant, Strategic Transformation, and Commercial Execution

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.